PAREXEL
2Q Revenues: $483.1 million (+25%)
2Q Earnings: $21.3 million (+65%)
YTD Revenues: $945.7 million (+26%)
YTD Earnings: $36.4 million (+62%)
Comments: Clinical Research Services (CRS) revenue was $320.6 million in the quarter, up 29%. PAREXEL Consulting & Medical Communications Services (PCMS) revenues were $49.3 million, up 28%. Perceptive Informatics (PI) revenues were $101.4 million, up 12%. Newly-acquired Liquent, Inc. contributed $0.4 million to revenue in the quarter. Backlog at the end of December 2012 was approximately $4.5 billion, up 21%.



